Close Menu

NEW YORK (GenomeWeb) – Cepheid announced today it has received CE-IVD clearance for a rapid molecular assay to measure viral load of hepatitis B in infected patients.

The Xpert HBV Viral Load test measures HBV DNA levels in plasma or serum using the firm's GeneXpert systems and provides quantitative results in less than one hour. It is intended to be used as an indicator of prognosis and to aid in assessing response to antiviral treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.